Truist Securities Maintains Hold on Cross Country Healthcare, Raises Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
Truist Securities maintains a Hold rating on Cross Country Healthcare (NASDAQ:CCRN) and raises the price target from $16 to $17.
August 01, 2024 | 1:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities maintains a Hold rating on Cross Country Healthcare and raises the price target from $16 to $17.
The raised price target from $16 to $17 indicates a positive outlook from Truist Securities, which could lead to a short-term increase in CCRN's stock price. However, the Hold rating suggests that the stock may not outperform the market significantly.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100